JPT Peptide Technologies

JPT Peptide Technologies GmbH, a wholly owned subsidiary of BioNTech AG, is a DIN ISO 9001:2008 certified research and development partner and innovative service provider for peptide related projects in immunotherapy development, proteomics and drug discovery. JPT’s key technologies SPOTTM â€" for ultra-high-throughput peptide synthesis and screening, PepStarTM â€" for high-content peptide microarrays, PepTrackTM - for flexible peptide library assembly, PepMixTM â€" for antigen specific T-cell stimulation using peptide pools, and SpikeTideTM & SpikeMixTM â€" for protein biomarker quantification accelerate research and development in areas such as immune monitoring, vaccine development, peptide biomarker discovery, peptide lead identification and optimization, enzyme profiling and proteomics.